KAITLIN C JAMES
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology NASHVILLE, TN NPI 1013064906
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Neurology with Special Qualifications in Child Neurology TN JAZZ PHARMACEUTICALS INC. All categories
General Payments — all program years on this page
$1,662.11
- Category: General Payments
- Program years: PY2018–2023
- Record count: 23
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $643.56 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $643.56 | 7 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| JAZZ PHARMACEUTICALS INC. | $192.38 | 1 |
| UCB, Inc. | $140.86 | 2 |
| CATALYST PHARMACEUTICALS, INC. | $132.91 | 2 |
| Neurelis, Inc. | $115.43 | 1 |
| SK Life Science, Inc. | $61.98 | 1 |
By program year
Records — PY2023 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1021525616 | UCB, Inc. | $58.64 | 12/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1021525623 | UCB, Inc. | $82.22 | 12/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048231605 | Catalyst Pharmaceuticals, Inc. | $12.15 | 12/01/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1048232173 | Catalyst Pharmaceuticals, Inc. | $120.76 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1054826141 | SK Life Science, Inc. | $61.98 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1057058797 | Neurelis, Inc. | $115.43 | 12/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1058430287 | JAZZ PHARMACEUTICALS INC. | $192.38 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.